title: Comment on: "The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia" by Spiel et al.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Messaris
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Memos
authors.forename: Frantzeska
authors.initials: F
authors.lastname: Frantzeskaki
authors.forename: Venetia
authors.initials: V
authors.lastname: Economou
authors.forename: Alex
authors.initials: A
authors.lastname: Betrosian
mesh_terms: D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000097:blood* / Q000188:drug therapy; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000188:drug therapy; D015850:Interleukin-6 / Q000097:blood; D011486:Protein C / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D018805:Sepsis / Q000097:blood / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015850:Interleukin-6; D011486:Protein C; D014409:Tumor Necrosis Factor-alpha